Last update 30 Sep 2025

etimumotide

Overview

Basic Info

Drug Type
Synthetic peptide vaccine, Therapeutic vaccine
Synonyms
PD-L1 peptide vaccine, IO 103, IO-103
+ [1]
Target
Action
inhibitors
Mechanism
PDL1 inhibitors(Programmed death-ligand 1 inhibitors)
Active Indication-
Originator Organization
Active Organization-
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Squamous Cell Carcinoma of Head and NeckPhase 2
Belgium
14 Aug 2020
Squamous cell carcinoma of the hypopharynxPhase 2
Belgium
14 Aug 2020
Squamous Cell Carcinoma of the LarynxPhase 2
Belgium
14 Aug 2020
Squamous cell carcinoma of the oral cavityPhase 2
Belgium
14 Aug 2020
Squamous Cell Carcinoma of the OropharynxPhase 2
Belgium
14 Aug 2020
Polycythemia VeraPhase 2
Denmark
10 Jul 2019
Thrombocythemia, EssentialPhase 2
Denmark
10 Jul 2019
Myeloproliferative DisordersPhase 2
Denmark
14 Jun 2019
Smoldering Multiple MyelomaPhase 2
Denmark
18 Feb 2019
Superficial basal cell carcinomaPhase 2
Denmark
01 Nov 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
43
PD-1 inhibitor
vmmfjrkcnv(jnsgyivjri) = ponwwdzett qzcfqktqsm (uiqeydzzsq )
-
06 Aug 2022
PD-L1 inhibitor
vmmfjrkcnv(jnsgyivjri) = jxsvjnypvx qzcfqktqsm (uiqeydzzsq )
Phase 2
10
zgmolylbdc(hmvwybuitw) = 9/10 induced in blood samples and 5/9 in skin-infiltrating lymphocytes eqnutmaapn (nhrznarfsw )
Positive
22 Feb 2021
Phase 1
10
xtcxwffpto(flskylqaln) = below CTCAE grade 3, and most were grade 1-2 injection site reactions fhmultcaec (vwbrnstrne )
Positive
09 Nov 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free